Research
Capital Region of Denmark
Amager Hospital
Bispebjerg Hospital
Bornholms Hospital
Frederiksberg Hospital
Frederikssund Hospital
Gentofte Hospital
Glostrup Hospital
Helsingør Hospital
Herlev Hospital
Hillerød Hospital
Hvidovre Hospital
Region Hovedstadens Psykiatri
Rigshospitalet
Print page
Switch language
Research and innovation
Statistics
Advanced search »
Hospitals/Units
Find departments and units at Region H
Researchers
Search for researchers at Region H
Publications
Search for publications from Region H
Journals
Search for journals from Region H
Publishers
Search for publishers from Region H
Projects
Search for projects/clinical trials from Region H
Activities
Search for activities from Region H have contributed
The Capital Region of Denmark
Projects
Dal - Gene
The Capital Region of Denmark - a part of Copenhagen University Hospital
Dal - Gene
Project
:
Types of projects
From the same participant
A phase III, double-blind, randomized placebo-controlled study to evaluate the effects of dalcetrapib on cardiovascular risk in genetically defined population with a recent acute coronary syndrome (DALCOR) www.ClinicalTrials.gov : NCT02525939
Project
:
Types of projects
SPIRE 1 & 2: A 52 Week Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study To Assess The Efficacy, Safety And Tolerability of PF-04950615 In Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events. Atherosclerotic Cardiovascular Disease (CVD)
Project
:
Types of projects
Augustus
Project
:
Types of projects
VERDICT trial
Project
:
Types of projects
Hilleroed Heart Study, diagnostic values of new biomakers in Ischemic Heart Disease
Project
:
Types of projects
Steffensen, Rolf
(Project participant)
Cardiology, Department of
,
Nordsjællands Hospital
View graph of relations
A Phase III, Double-blind, Randomized Placebo-controlled Study to Evaluate the Effects of Dalcetrapib on Cardiovascular (CV) Risk in a Genetically Defined Population With a Recent Acute Coronary Syndrome (ACS): The Dal-GenE Trial
www.clinicaltrials.gov : NCT02525939
Status
Current
Period
01/04/2016
→
01/08/2020
ID: 58247364